Since IFN-γ of TME is generally considered to be beneficial for immunotherapy, tumor cells may undergo survival-stressed proliferation when the IFN-γ signaling pathway is defective (Abril-Rodriguez and Ribas, 2017). The gene discussed is IFNG; the disease is neoplasm.